Author:
Guo Chenyan,Tao Xiang,Zhang Lihong,Zhang Ying,Hua Keqin,Qiu Junjun
Abstract
Abstract
Background
Considering the unique biological behavior of cervical adenocarcinoma (AC) compared to squamous cell carcinoma, we now lack a distinct method to assess prognosis for AC patients, especially for intermediate-risk patients. Thus, we sought to establish a Silva-based model to predict recurrence specific for the intermediate-risk AC patients and guide adjuvant therapy.
Methods
345 AC patients were classified according to Silva pattern, their clinicopathological data and survival outcomes were assessed. Among them, 254 patients with only intermediate-risk factors were identified. The significant cutoff values of four factors (tumor size, lymphovascular space invasion (LVSI), depth of stromal invasion (DSI) and Silva pattern) were determined by univariate and multivariate Cox analyses. Subsequently, a series of four-, three- and two-factor Silva-based models were developed via various combinations of the above factors.
Results
(1) We confirmed the prognostic value of Silva pattern using a cohort of 345 AC patients. (2) We established Silva-based models with potential recurrence prediction value in 254 intermediate-risk AC patients, including 12 four-factor models, 30 three-factor models and 16 two-factor models. (3) Notably, the four-factor model, which includes any three of four intermediate-risk factors (Silva C, ≥ 3 cm, DSI > 2/3, and > mild LVSI), exhibited the best recurrence prediction performance and surpassed the Sedlis criteria.
Conclusions
Our study established a Silva-based four-factor model specific for intermediate-risk AC patients, which has superior recurrence prediction performance than Sedlis criteria and may better guide postoperative adjuvant therapy.
Funder
the Research and Innovation Project of the Shanghai Municipal Education Commission
the Clinical Research Plan of SHDC
National Natural Science Foundation of China
the Natural Science Foundation of Shanghai Science and Technology
the Shanghai “Rising Stars of Medical Talent” Youth Development Program
Shanghai Municipal Health Commission
the special project of Medical Innovation Research of Shanghai Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,General Medicine
Reference25 articles.
1. Kurman RJLM, Simon Herrington C, et al. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: Int Agency Res Cancer; 2014. p. 184.
2. Fujiwara H, Yokota H, Monk B, et al. Gynecologic cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2014;24(9 Suppl 3):S96-101.
3. Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet (London, England). 2001;357(9267):1490–3.
4. Bray F, Carstensen B, Møller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cospons Am Soc Prev Oncol. 2005;14(9):2191–9.
5. Berek JS, Hacker NF, Fu YS, et al. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol. 1985;65(1):46–52.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献